Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.021 | 0.7 |